Cargando…
A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype
BACKGROUND: Immune checkpoint blockade (ICB) has been approved for the treatment of triple-negative breast cancer (TNBC), since it significantly improved the progression-free survival (PFS). However, only about 10% of TNBC patients could achieve the complete response (CR) to ICB because of the low r...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484710/ https://www.ncbi.nlm.nih.gov/pubmed/34603338 http://dx.doi.org/10.3389/fimmu.2021.749459 |